Astellas Venture Management
AV
About
AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. For over 15 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research.
Key facts
- Website
- astellasventure.com
- Type
- Corporate Venture Capital
- Headquarters
- United States
- Portfolio companies
- 2
- Stages
- Pre-SeedSeries C
- Cheque size
- $5M to $46M
- Sector focus
- Life SciencesDigital TwinTherapeuticsGenetics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 3 Sept 2024 | Somite.ai | Pre-Seed | $5M |
| 28 Oct 2013 | Crescendo | Undisclosed round | $18M |
Add first review
Frequently asked
What companies has Astellas Venture Management invested in?
Astellas Venture Management has invested in Somite.ai, Crescendo.